Article Information
History
- January 21, 2021.
Article Versions
- You are currently viewing Version 1 of this article (January 21, 2021 - 15:26).
- Version 2 (December 5, 2021 - 05:15).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Nuria Vilaplana-Lopera1,
- Ruba Almaghrabi1,
- Grigorios Papatzikas1,
- Elena González1,
- Alan Cunningham2,
- Ayşegül Erdem2,
- Frank Schnuetgen3,4,5,
- Manoj Raghavan1,6,
- Sandeep Potluri1,6,
- Jean-Baptiste Cazier1,
- Jan Jacob Schuringa2,
- Michelle AC Reed1,
- Ulrich L Günther1,7,* and
- Paloma Garcia1,8,*
- 1Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
- 2Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands
- 3Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt, Germany
- 4Frankfurt Cancer Institute, Goethe-University Frankfurt, 60596 Frankfurt, Germany
- 5German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany
- 6Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham, United Kingdom
- 7Institute of Chemistry and Metabolomics, University of Lübeck, 23562 Lübeck, Germany
- ↵8Corresponding author; email: p.garcia{at}bham.ac.uk